Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 69097-741

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 69097-741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 01)

Image (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 01)
Chemical structure of EMTRICITABINE, one of the active ingredients in the combination drug EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE. The structure shows a nucleoside analog with a fluorinated pyrimidine ring and a sulfur-containing sugar moiety.*
FDA Label Image

Image (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 02)

Image (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 02)
Chemical structure diagram depicting the molecular arrangement of emtricitabine and tenofovir disoproxil fumarate, the active ingredients in the EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE product by Cipla USA Inc.*
FDA Label Image

30 Tablets (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 03)

30 Tablets (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 03)
Label for Emtricitabine and Tenofovir Disoproxil Fumarate tablets 200 mg/300 mg manufactured by Cipla USA Inc. The film-coated oral tablets come in a 30-count package. The label includes dosage strengths, manufacturer information, storage instructions, barcode, and space for batch overprinting of serial number, expiry, and lot details.*
FDA Label Image

Container-appco (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 04)

Container-appco (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 04)
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg film-coated oral tablets packaging label. The label includes dosage strength, active ingredient names, manufacturer Cipla USA Inc., storage instructions, and safety warnings. It shows the product as a human prescription drug with clear NDC 69097-741-02 and a 'No Varnish' notice.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.